logo

For the Inventor, By the Inventor

Austin, TX, United States of America

Vermillion Corporation


USPTO Granted Patents = 26

% Expired Patents = 26.9


Trademarks = 13

Forward Citations = 209

Loading Chart...
Loading Chart...

47 inventors (with patents filed for the assignee):

goldMedal Eric Thomas Fung (14 out of 20 patents)

silverMedal John P Cooke (6 out of 43 patents)

bronzeMedal Tai-Tung Yip (5 out of 35 patents)

4.  Vladimir Podust (4 out of 10 patents)

5.  Zhen Zhang (4 out of 17 patents)

6.  Ping F Yip (4 out of 4 patents)

7.  Suraj Amonkar (4 out of 4 patents)

8.  Greg P Bertenshaw (4 out of 4 patents)

9.  Daniel W Chan (4 out of 11 patents)

10.  Brian C Mansfield (4 out of 5 patents)

11.  Xiao-Ying Meng (4 out of 4 patents)

12.  Walter Wilcox Cardwell, Iii (4 out of 5 patents)

13.  Stephen Andrew Stickel (4 out of 4 patents)

14.  Fujun Zhang (3 out of 4 patents)

15.  Eiichiro Kimura (3 out of 19 patents)


Core Competencies:
Ovarian Cancer
Biomarkers
Peripheral Artery Disease
CTAP3
Beta-2 Microglobulin
Cancer Diagnostics
Panel of Biomarkers
Lung Cancer
Alzheimer's Disease
Natriuretic Peptides
Nephrotic Syndrome
Diagnostic Methods

26 patents:

1. 10605811 - Predictive biomarkers for ovarian cancer (2020-03-31),
2. 9846158 - Predictive biomarkers for ovarian cancer (2017-12-19),
3. 9816995 - Biomarker for ovarian cancer CTAP3-related proteins (2017-11-14),
4. 9274118 - Predictive markers for ovarian cancer (2016-03-01),
5. 8709735 - β-2 microglobulin as a biomarker for peripheral artery disease (2014-04-29),
6. 8682591 - Biomarkers for ovarian cancer (2014-03-25),
7. 8664358 - Predictive markers for ovarian cancer (2014-03-04),
8. 8465929 - Biomarkers for ovarian cancer (2013-06-18),
9. 8377646 - Beta-2 microglobulin as a biomarker for peripheral artery disease (2013-02-19),
10. 8221984 - Biomarkers for ovarian cancer (2012-07-17),
11. 8206934 - Methods for diagnosing ovarian cancer (2012-06-26),
12. 8173433 - Platelet biomarkers for cancer (2012-05-08),
13. 8053204 - Beta-2 microglobulin as a biomarker for peripheral artery disease (2011-11-08),
14. 8014952 - Serum biomarkers in lung cancer (2011-09-06),
15. 8008020 - Biomarkers for peripheral artery disease (2011-08-30),
Vermillion Corporation is a biotechnology company based in Austin, Texas, specializing in the development of innovative diagnostics and therapeutic solutions. The organization focuses on women's health, particularly in the areas of ovarian cancer and other gynecological conditions, leveraging advanced biomarker technologies to enhance patient outcomes. Through its commitment to research and development, Vermillion aims to provide healthcare professionals with critical tools for early detection and personalized treatment strategies.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Vermillion Corporation
26 Patents

#116 in Austin, TX

#739 in Texas

#12,850 in US

#24,781 in the World

Austin, TX (US)
Austin, TX, United States of America

Vermillion Corporation

Forward Citations = 209

47 inventors:

goldMedal Eric Thomas Fung (14 out of 20 patents)

silverMedal John P Cooke (6 out of 43 patents)

bronzeMedal Tai-Tung Yip (5 out of 35 patents)

4.  Vladimir Podust (4 out of 10 patents)

5.  Zhen Zhang (4 out of 17 patents)

Please report any incorrect information to [email protected]
Loading…